ScreenPoint Medical

Company Overview

Transpara by ScreenPoint Medical is a radiology decision support tool for FFDM and DBT that can improve workflow, confidence and results in screening mammography.

It is an enhanced decision support for early breast cancer detection and diagnosis using deep learning. The software is flexible, works with any acquisition gantry and can be read in any customer-preferred reading environment.

Transpara was launched in 2014 and was first to be FDA and CE cleared for both FFDM and DBT. They analyzed four million scans by May 2023 and have more peer-reviewed publications than any other breast AI vendor. Transpara by ScreenPoint Medical is the pace setter for Breast AI solutions – trusted by academics and large screening programs to support better care for women.

Their mission is to provide smart AI for earlier breast cancer detection and diagnosis, so that women can live healthier, fuller lives.

Modalities